Our pooled results also found that elevated levels of CRP are greatly related to the shortening of OS in patients with osteosarcoma (HR = 1.96, 95% CI: 1.28-3.00) which conforms to the outcomes of most researches [13, 18, 19, 21]. The gene discussed is CRP; the disease is osteosarcoma.